Advanced search

Outcome of highly pathogenic PRRSV1 subtype 3 in pigs immune after infection with PRRSV1 subtype 1 and after vaccination with commercial and new experimental attenuated vaccines

Ivan Trus (UGent)
(2017)
Author
Promoter
(UGent)
Organization
Keywords
PRRSV1, Subtype 1, Subtype 3, cross-protection, immunization, vaccine, attenuation, MLV

Citation

Please use this url to cite or link to this publication:

Chicago
Trus, Ivan. 2017. “Outcome of Highly Pathogenic PRRSV1 Subtype 3 in Pigs Immune After Infection with PRRSV1 Subtype 1 and After Vaccination with Commercial and New Experimental Attenuated Vaccines”. Merelbeke, Belgium: Ghent University. Faculty of Veterinary Medicine.
APA
Trus, I. (2017). Outcome of highly pathogenic PRRSV1 subtype 3 in pigs immune after infection with PRRSV1 subtype 1 and after vaccination with commercial and new experimental attenuated vaccines. Ghent University. Faculty of Veterinary Medicine, Merelbeke, Belgium.
Vancouver
1.
Trus I. Outcome of highly pathogenic PRRSV1 subtype 3 in pigs immune after infection with PRRSV1 subtype 1 and after vaccination with commercial and new experimental attenuated vaccines. [Merelbeke, Belgium]: Ghent University. Faculty of Veterinary Medicine; 2017.
MLA
Trus, Ivan. “Outcome of Highly Pathogenic PRRSV1 Subtype 3 in Pigs Immune After Infection with PRRSV1 Subtype 1 and After Vaccination with Commercial and New Experimental Attenuated Vaccines.” 2017 : n. pag. Print.
@phdthesis{8529698,
  author       = {Trus, Ivan},
  language     = {eng},
  pages        = {III, 155},
  publisher    = {Ghent University. Faculty of Veterinary Medicine},
  school       = {Ghent University},
  title        = {Outcome of highly pathogenic PRRSV1 subtype 3 in pigs immune after infection with PRRSV1 subtype 1 and after vaccination with commercial and new experimental attenuated vaccines},
  year         = {2017},
}